Cargando…
EHMTI-0022. Pharmacokinetic variability of drugs used for prophylactic treatment in migraine
Autores principales: | Pavbro, P, Tfelt-Hansen, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181994/ http://dx.doi.org/10.1186/1129-2377-15-S1-G36 |
Ejemplares similares
-
EHMTI-0120. Are the IHS’ recommendations for evaluation and registration of adverse events in drug trials in migraine being followed ?
por: Tfelt-Hansen, P, et al.
Publicado: (2014) -
EHMTI-0368. Treatment of migraine attacks as suggested by Dr. John R. Graham in 1955. A historical analysis with current implications
por: Tfelt-Hansen, P, et al.
Publicado: (2014) -
EHMTI-0044. Variability of clinical features in attacks of migraine with aura
por: Hansen, J Møller, et al.
Publicado: (2014) -
EHMTI-0336. Metabolic diet therapy in the prophylactic treatment of migraine headache in adolescents by using ketogenic diet
por: Farkas, MK, et al.
Publicado: (2014) -
EHMTI-0175. Analysis of migraine among Nepalese population: classification, triggering factors, prophylactic and abortive treatment
por: Ojha, R, et al.
Publicado: (2014)